{"entity":{"type":"insider","cik":"0001537668","url":"/insider/0001537668","json_url":"/insider/0001537668.json","name":"White Christopher G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":12,"first":"2012-01-10","last":"2024-02-06","span_basis":"filed_date"},"name_variants":[{"name":"White Christopher G","source":"filing","n_filings":12,"first_seen":"2012-01-10","last_seen":"2024-02-06"}],"transactions":[{"id":2998179,"accession":"0001104659-24-011201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-011201","line_url":"/filing/0001104659-24-011201#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5910.0,"shares_display":"5,910","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":28722.6,"total_display":"28,722.60","shares_owned_after":123689.0,"shares_owned_after_display":"123,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-06","scope":"insider"},{"id":3153785,"accession":"0001104659-24-010233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-010233","line_url":"/filing/0001104659-24-010233#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5147.0,"shares_display":"5,147","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":25477.65,"total_display":"25,477.65","shares_owned_after":89619.0,"shares_owned_after_display":"89,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":7921766,"accession":"0001104659-23-014686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-014686","line_url":"/filing/0001104659-23-014686#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5829.0,"shares_display":"5,829","price_per_share":4.24,"price_display":"4.24","price_state":"stated","total_value":24714.96,"total_display":"24,714.96","shares_owned_after":94766.0,"shares_owned_after_display":"94,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":7080903,"accession":"0001179110-14-003749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-003749","line_url":"/filing/0001179110-14-003749#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":21.58,"price_display":"21.58","price_state":"stated","total_value":8632.0,"total_display":"8,632.00","shares_owned_after":24000.0,"shares_owned_after_display":"24,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-26","filed_date":"2014-02-26","scope":"insider"},{"id":7080901,"accession":"0001179110-14-003749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-003749","line_url":"/filing/0001179110-14-003749#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":434.0,"shares_display":"434","price_per_share":21.71,"price_display":"21.71","price_state":"stated","total_value":9422.14,"total_display":"9,422.14","shares_owned_after":24400.0,"shares_owned_after_display":"24,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-25","filed_date":"2014-02-26","scope":"insider"},{"id":6333605,"accession":"0001179110-14-000786","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-000786","line_url":"/filing/0001179110-14-000786#line-4","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":20.61,"price_display":"20.61","price_state":"stated","total_value":35037.0,"total_display":"35,037.00","shares_owned_after":25134.0,"shares_owned_after_display":"25,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-09","filed_date":"2014-01-09","scope":"insider"},{"id":6333602,"accession":"0001179110-14-000786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-000786","line_url":"/filing/0001179110-14-000786#line-3","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":22.41,"price_display":"22.41","price_state":"stated","total_value":4482.0,"total_display":"4,482.00","shares_owned_after":24834.0,"shares_owned_after_display":"24,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-09","filed_date":"2014-01-09","scope":"insider"},{"id":6333599,"accession":"0001179110-14-000786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-000786","line_url":"/filing/0001179110-14-000786#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":21.4,"price_display":"21.40","price_state":"stated","total_value":2140.0,"total_display":"2,140.00","shares_owned_after":25034.0,"shares_owned_after_display":"25,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-09","filed_date":"2014-01-09","scope":"insider"},{"id":6333596,"accession":"0001179110-14-000786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-000786","line_url":"/filing/0001179110-14-000786#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":23.91,"price_display":"23.91","price_state":"stated","total_value":47820.0,"total_display":"47,820.00","shares_owned_after":26834.0,"shares_owned_after_display":"26,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-08","filed_date":"2014-01-09","scope":"insider"},{"id":7017917,"accession":"0001179110-14-000628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-000628","line_url":"/filing/0001179110-14-000628#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":24.1,"price_display":"24.10","price_state":"stated","total_value":60250.0,"total_display":"60,250.00","shares_owned_after":28834.0,"shares_owned_after_display":"28,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-07","filed_date":"2014-01-07","scope":"insider"},{"id":7017915,"accession":"0001179110-14-000628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-000628","line_url":"/filing/0001179110-14-000628#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.69,"price_display":"23.69","price_state":"stated","total_value":59225.0,"total_display":"59,225.00","shares_owned_after":31334.0,"shares_owned_after_display":"31,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-06","filed_date":"2014-01-07","scope":"insider"},{"id":4729335,"accession":"0001179110-13-003542","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-003542","line_url":"/filing/0001179110-13-003542#line-3","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":16.37,"price_display":"16.37","price_state":"stated","total_value":6548.0,"total_display":"6,548.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-26","filed_date":"2013-02-26","scope":"insider"},{"id":4729327,"accession":"0001179110-13-003542","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-003542","line_url":"/filing/0001179110-13-003542#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":433.0,"shares_display":"433","price_per_share":16.39,"price_display":"16.39","price_state":"stated","total_value":7096.87,"total_display":"7,096.87","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-25","filed_date":"2013-02-26","scope":"insider"},{"id":5249129,"accession":"0001179110-13-000738","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-13-000738","line_url":"/filing/0001179110-13-000738#line-4","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.8022,"price_display":"15.80","price_state":"stated","total_value":47406.6,"total_display":"47,406.60","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-09","filed_date":"2013-01-09","scope":"insider"},{"id":5249124,"accession":"0001179110-13-000738","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-000738","line_url":"/filing/0001179110-13-000738#line-3","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.8665,"price_display":"15.87","price_state":"stated","total_value":47599.5,"total_display":"47,599.50","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-08","filed_date":"2013-01-09","scope":"insider"},{"id":5249121,"accession":"0001179110-13-000738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-000738","line_url":"/filing/0001179110-13-000738#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":16.0712,"price_display":"16.07","price_state":"stated","total_value":64284.8,"total_display":"64,284.80","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-07","filed_date":"2013-01-09","scope":"insider"},{"id":5496937,"accession":"0001104659-13-001077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-13-001077","line_url":"/filing/0001104659-13-001077#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":16.0254,"price_display":"16.03","price_state":"stated","total_value":64101.6,"total_display":"64,101.60","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-04","filed_date":"2013-01-07","scope":"insider"},{"id":3401512,"accession":"0001242616-12-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001242616-12-000016","line_url":"/filing/0001242616-12-000016#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer, SVP)","officer_title":"Chief Business Officer, SVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":14.29,"price_display":"14.29","price_state":"stated","total_value":53587.5,"total_display":"53,587.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-06","filed_date":"2012-08-07","scope":"insider"},{"id":2461727,"accession":"0001317757-12-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001317757-12-000014","line_url":"/filing/0001317757-12-000014#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer and SVP)","officer_title":"Chief Business Officer and SVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":833.0,"shares_display":"833","price_per_share":15.82,"price_display":"15.82","price_state":"stated","total_value":13178.06,"total_display":"13,178.06","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-24","scope":"insider"},{"id":2174097,"accession":"0001317757-12-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001317757-12-000006","line_url":"/filing/0001317757-12-000006#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001537668","owner_name":"White Christopher G","owner_url":"/insider/0001537668","role":"Officer (Chief Business Officer and SVP)","officer_title":"Chief Business Officer and SVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":17.0878,"price_display":"17.09","price_state":"stated","total_value":136702.4,"total_display":"136,702.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-09","filed_date":"2012-01-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Officer (Chief Business Officer)","n_filings":3,"first_seen":"2023-02-08","last_seen":"2024-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Officer (Chief Business Officer)","n_filings":9,"first_seen":"2012-01-10","last_seen":"2014-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001537668","retrieved_at":"2026-08-21T20:58:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}